<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hyperfine Inc — News on 6ix</title>
<link>https://6ix.com/company/hyperfine-inc</link>
<description>Latest news and press releases for Hyperfine Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 09 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/hyperfine-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683580b378dffbe2df0fb8be.webp</url>
<title>Hyperfine Inc</title>
<link>https://6ix.com/company/hyperfine-inc</link>
</image>
<item>
<title>Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-receives-ce-and-ukca-marks-for-next-generation-swoopr-system-and-latest-advancement-in-optive-aitm-software</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-receives-ce-and-ukca-marks-for-next-generation-swoopr-system-and-latest-advancement-in-optive-aitm-software</guid>
<pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
<description>This milestone unlocks Hyperfine’s most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom,</description>
</item>
<item>
<title>Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine</title>
<link>https://6ix.com/company/hyperfine-inc/news/horizon-technology-finance-provides-dollar40-million-loan-facility-to-hyperfine-2</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/horizon-technology-finance-provides-dollar40-million-loan-facility-to-hyperfine-2</guid>
<pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
<description>FARMINGTON, Conn., March 23, 2026--Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) ("Hyperfine"), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth.</description>
</item>
<item>
<title>Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
<description>GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the</description>
</item>
<item>
<title>Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-18-2026-71</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-18-2026-71</guid>
<pubDate>Thu, 05 Mar 2026 21:05:00 GMT</pubDate>
<description>GUILFORD, Conn., March 05, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, March 18, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.</description>
</item>
<item>
<title>Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-publication-breakthrough-clinical-131500165</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-publication-breakthrough-clinical-131500165</guid>
<pubDate>Tue, 27 Jan 2026 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., January 27, 2026--Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.</description>
</item>
<item>
<title>Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-neuro-pmr-study-131500777</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-neuro-pmr-study-131500777</guid>
<pubDate>Tue, 20 Jan 2026 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., January 20, 2026--Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.</description>
</item>
<item>
<title>Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-enrollment-first-patient-131500774</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-enrollment-first-patient-131500774</guid>
<pubDate>Thu, 15 Jan 2026 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., January 15, 2026--Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.</description>
</item>
<item>
<title>Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-reports-preliminary-unaudited-fourth-131500190</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-reports-preliminary-unaudited-fourth-131500190</guid>
<pubDate>Mon, 12 Jan 2026 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., January 12, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31, 2025.</description>
</item>
<item>
<title>Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors</title>
<link>https://6ix.com/company/hyperfine-inc/news/pulse-biosciences-inc-appoints-maria-sainz-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/pulse-biosciences-inc-appoints-maria-sainz-to-its-board-of-directors</guid>
<pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
<description>HAYWARD, Calif., January 09, 2026--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026.</description>
</item>
<item>
<title>Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-first-peer-reviewed-131500933</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-first-peer-reviewed-131500933</guid>
<pubDate>Tue, 06 Jan 2026 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., January 06, 2026--Hyperfine announces the first analysis showing the AI-powered Swoop® portable MRI system reduces hospital costs and improves economics in acute care.</description>
</item>
<item>
<title>Hyperfine Announces Regulatory Approval of the Swoop® System in India</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-regulatory-approval-swoop-131500797</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-regulatory-approval-swoop-131500797</guid>
<pubDate>Wed, 17 Dec 2025 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., December 17, 2025--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.</description>
</item>
<item>
<title>Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-fda-clearance-first-131500175</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-fda-clearance-first-131500175</guid>
<pubDate>Mon, 15 Dec 2025 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., December 15, 2025--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.</description>
</item>
<item>
<title>Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-participate-upcoming-piper-210500752</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-participate-upcoming-piper-210500752</guid>
<pubDate>Thu, 20 Nov 2025 21:05:00 GMT</pubDate>
<description>GUILFORD, Conn., November 20, 2025--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.</description>
</item>
<item>
<title>Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-awarded-3-7-million-131500455</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-awarded-3-7-million-131500455</guid>
<pubDate>Wed, 19 Nov 2025 13:15:00 GMT</pubDate>
<description>GUILFORD, Conn., November 19, 2025--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.</description>
</item>
<item>
<title>Hyperfine, Inc. Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-reports-third-quarter-210500761</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-reports-third-quarter-210500761</guid>
<pubDate>Thu, 13 Nov 2025 21:05:00 GMT</pubDate>
<description>GUILFORD, Conn., November 13, 2025--Hyperfine today announced third quarter 2025 financial results and provided a business update.</description>
</item>
<item>
<title>Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-announce-third-quarter-200500006</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-inc-announce-third-quarter-200500006</guid>
<pubDate>Thu, 30 Oct 2025 20:05:00 GMT</pubDate>
<description>GUILFORD, Conn., October 30, 2025--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report full financial results for the third quarter 2025 on Thursday, November 13, 2025. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.</description>
</item>
<item>
<title>Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-first-patients-enrolled-121500613</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-first-patients-enrolled-121500613</guid>
<pubDate>Tue, 21 Oct 2025 12:15:00 GMT</pubDate>
<description>GUILFORD, Conn., October 21, 2025--Hyperfine launches study to assess Swoop® System use in neurosurgical ORs, advancing accessible brain MRI across care settings.</description>
</item>
<item>
<title>Hyperfine Announces Pricing of $17.5 Million Public Offering</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-pricing-17-5-120000328</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-pricing-17-5-120000328</guid>
<pubDate>Thu, 16 Oct 2025 12:00:00 GMT</pubDate>
<description>GUILFORD, Conn., October 16, 2025--Hyperfine, Inc. (Nasdaq: HYPR) ("Hyperfine" or the "Company") today announced it has priced its previously announced underwritten public offering of 14,000,000 shares of the Company’s Class A common stock at a public offering price of $1.25 per share. All of the shares in the offering are being sold by Hyperfine. In addition, Hyperfine has granted the underwriter a 30-day option to purchase up to 2,100,000 shares of Class A common stock, which equals 15% of the</description>
</item>
<item>
<title>Hyperfine Announces Proposed Public Offering</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-proposed-public-offering-200600308</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-announces-proposed-public-offering-200600308</guid>
<pubDate>Wed, 15 Oct 2025 20:06:00 GMT</pubDate>
<description>GUILFORD, Conn., October 15, 2025--Hyperfine, Inc. (Nasdaq: HYPR) ("Hyperfine" or the "Company") today announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase Class A common stock. All securities to be sold in the offering will be sold by Hyperfine. In addition, Hyperfine intends to grant the underwriters a 30-day option to purchase up to 15% of the total number of securi</description>
</item>
<item>
<title>Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System</title>
<link>https://6ix.com/company/hyperfine-inc/news/hyperfine-reports-preliminary-unaudited-results-200500194</link>
<guid isPermaLink="true">https://6ix.com/company/hyperfine-inc/news/hyperfine-reports-preliminary-unaudited-results-200500194</guid>
<pubDate>Wed, 15 Oct 2025 20:05:00 GMT</pubDate>
<description>GUILFORD, Conn., October 15, 2025--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited financial results for the third quarter ended September 30, 2025.</description>
</item>
</channel>
</rss>